Medical Treatment of Cushing's Disease with Pasireotide Mono- or Combination Therapy with Cabergoline and Ketoconazole Modulates Somatostatin Receptor Subtype Expression on Corticotroph Tumor Cells

Author(s):
Feelders, R.A.; Bruin, C. de; Pereira, A.M.; Romijn, J.A.; Netea-Maier, R.T.; Hermus, A.R.; Zelissen, P.M.; Sprij-Mooij, D.M.; Lely, A.J. van der; Herder, W.W. de; Lamberts, S.W.J.; Hofland, L.J.
Published
2010
Publication type
Article / Letter to editor
Date issued
2010-06-30
Language
English
Is part of
Endocrine Reviews (2010), Vol. 31, no. 3, p. S845-S845
hdl
1887/118249